European Movers: Sanofi (SAN FP) +3.4%, Infineon (IFX GY) +2.4%, ASML (ASML NA) +1.3%, UBS (UBSG SW) -1.2%, Land Securities (LAND LN) -1.9%

A movers round-up of this kind is a snapshot rather than a signal: individual names of this size rarely travel together unless there is a shared thread, and the read here splits into cases.

Newsquawk StaffPublished On the live feed at , 20 minutes before this page
Newsquawk headlinesUTC

European Movers: Sanofi (SAN FP) +3.4%, Infineon (IFX GY) +2.4%, ASML (ASML NA) +1.3%, UBS (UBSG SW) -1.2%, Land Securities (LAND LN) -1.9%

Israeli Security Cabinet to discuss situation "on all fronts" on Sunday, Al Hadath reports

[MARKET UPDATE] Energy lifts, Brent Jan'27 back into the green, weighing on European equity futures (FTSE 100 -1.0%) and fixed income benchmarks, lifting yields and in-turn the USD

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

The semiconductor bid (Infineon, ASML) fits the established pattern of the European chip complex trading as a block off overnight US and Asian peer moves and any supply-chain or capex commentary, with ASML historically the higher-beta expression of equipment orders sentiment. Sanofi's outperformance in pharma tends to be name-specific, pipeline, trial, or broker driven, rather than sector-wide, so the accompanying wires matter more than the print. On the downside, UBS softness against a firm tape has in past episodes traced to capital-return expectations, integration headlines, or Swiss regulatory noise, while Land Securities moves with the gilt long end and rate expectations more than with equity beta, so the rates tape is the first cross-check. Absent a cited catalyst, the precedents counsel caution: single-session movers lists frequently reverse or consolidate by the close, and the durable signal is whether the move survives into the next session on volume.

Related headlines

The whole workspace, free to try.

Try it free